4 articles
A Landmark Moment in Cancer Treatment Drugmakers Moderna and Merck have announced that a personalized mRNA cancer vaccine, given alongside the immunotherapy drug Keytruda, significantly...
Personalized mRNA Cancer Vaccine Shows Breakthrough Results in Melanoma Trial A personalized mRNA cancer vaccine developed by pharmaceutical giants Merck and Moderna has shown significant...
Michelle Goveia, MD, Executive Director, Global Medical and Scientific Affairs at Merck Vaccines and Dr. Learn more on Health Professional Radio.
Pritesh Shah, Chief Commercial Officer of device maker Novocure® discusses Tumor Treating Fields, a cap-like device that aims electric fields at cancer...